Skip to content
★ Sign in to follow
周

周明康

毕得医药
Insider activity · 24 months0 buys3 salesCumulative net flow
Total declarations
3
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (3 ops.)
€103k

Latest filing published 23 Sept 2026 for 毕得医药, €11k.

Filing timeline

BuySale
周明康

Insider track record

Disclosed buys
0
Disclosed sells
3
Signal history

周明康: trading record in brief

周明康 discloses dealings in 毕得医药 to SSE / SZSE (CSRC). In total, 3 filings cover trades dated from 7 September 2026 to 23 September 2026.

On the market, this insider has only sold: 3 sales, €103k in total.

The record was last updated on 23 September 2026 with an open-market sale (€11k) in 毕得医药. Publication is fast: at least half of the trades appear on SSE / SZSE (CSRC) on the same day. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.

Companies and markets linked to 周明康

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▼
    核心技术人员Executives毕得医药
    80,650 CNY22SSE
    1,000 shares@ CN¥618.077310.2% of flowA股XSHGSSE:273000001580436400
  • ▼
    核心技术人员Executives毕得医药
    159,560 CNY24SSE
    2,500 shares@ CN¥498.082419.9% of flowA股XSHGSSE:273000001471587200
  • ▼
    核心技术人员Executives毕得医药
    561,051 CNY29SSE
    9,500 shares@ CN¥460.268569.9% of flowA股XSHGSSE:273000001466505950

3 of 3 declarations